Diverticular colon disease in the practice of general practitioner


S.V. Levchenko

State budgetary institution of high professional education «Moscow State University of Medicine and Dentistry named after A.I. Evdokimov» of the Ministry of Healthcare of the Russian Federation, Moscow
The article presents the main stages of the algorithm of management of patients with various forms of diverticular colon disease on the outpatient stage of medical care, based on the modern data on the frequency of diverticular colon disease and risk factors for its complications.
Keywords: butyrate, diverticular colon disease, rifaximin, mesalazine, dietary fiber, outpatient treatment, diverticulitis
Read entire article

Literature

  • Lazebnik L., Baryshnikov E., Parfenov A., Prilepskaja S. et al. First results of epidemiological study MUZe (prevalence of colon diverticulosis, colorectal polips and colorectal cancer among adult population of Moscow with chronic constipation and alarm symptoms). Scandinavian J. of Gastroent., 2010, V.45(suppl.247):86
  • Viniol A., Keunecke C., Biroga T., Stadje R., Dornieden K., Bösner S., Donner-Banzhoff N., Haasenritter J., Becker A. Studies of the symptom abdominal pain-a systematic review and meta-analysis. Fam Pract. 2014 Oct;31(5):517-29. doi: 10.1093/fampra/cmu036
  • Kang J.Y., Firwana B., Green A.E. et al. Uncomplicated diverticular disease is not a common cause of colonic symptoms. Aliment.Pham.Ther., 2011, Vol.33(4),P.487-494
  • Stollman N.H., Morgan R. et al. Hospitalizations for diverticular disease. Effects of age on presentation. Am.J.Gastroenterol., 1999, Vol.11, P.3110-21
  • Humes DJ, Spiller RC. Review article: The pathogenesis and management of acute colonic diverticulitis. Aliment Pharmacol Ther. 2014 Feb;39(4):359-70. doi: 10.1111/apt.12596
  • Jackson J.D., Hammond T. Systematic review: outpatient management of acute uncomplicated diverticulitis. Int J Colorectal Dis. 2014 Jul;29(7):775-81. doi: 10.1007/s00384-014-1900-4
  • Tursi A. Efficacy, safety, and applicability of outpatient treatment for diverticulitis. Drug Healthc Patient Saf. 2014 Mar 31;6:29-36. doi: 10.2147/DHPS.S61277. eCollection 2014
  • Humes D.J., Spiller R.C. Review article: The pathogenesis and management of acute colonic diverticulitis. Aliment Pharmacol Ther. 2014 Feb;39(4):359-70. doi: 10.1111/apt.12596
  • Aldoori W.H., Giovannucci E.L., Rockett H.R. et al. A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr 1998;128:714-9
  • Головенко О.В., Халиф И.Л., Головенко А.О. Роль масляной кислоты и инулина в лечении органических и функциональных заболеваний кишечника. Пособие для врачей. Москва, 2012, 40 стр. [Golovenko O.V., Khalif I.L., Golovenko A.O. Role of butyric acid and inuline in organic and functional intestinal diseases treatment. Manual for physicians. Moscow, 2012, p. 40.]
  • Jeong J.H., Lee H.L. et al. Correlation between complicated diverticulitis and visceral fat. J.Korean Med. Sci., 2011, 26(10). P.1339-43
  • Strate L.L., Liu Y.L., Aldoori W.H. et al. Obesity increases the risks of diverticulitis and diverticular bleeding, Gastroenterol., 2009, 136(1), P.115-22
  • Kopylov U., Ben-Horin S., Lahat A., Segev S. Obesity, metabolic syndrome and the risk of development of colonic diverticulosis, Digestion 2012;86(3):201-5
  • Korzenik J.R. Diverticulitis: new frontiers for an old country: risk factors and pathogenesis. NDSG.J Clin Gastroenterol., 2008;42(10):1128-9
  • Strate L.L., Liu Y.L., Aldoori W.H. et al. Physical activity decreases diverticular complications. Am.J. Gastroenterol., 2009, 104(5), P.1221-30
  • Левченко С.В., Лазебник Л.Б., Потапова В.Б., Рогозина В.А. Клинико-морфологические варианты дивертикулярной болезни толстой кишки Экспериментальная и клиническая гастроэнтерология. 2013;3:24-31 [Levchenko S.V., Lazebnik L.B., Potapova V.B., Rogozina V.A. Clinical morphological variant of diverticulous colonal disease.Experimental and clinical gastroenterology. 2013;3:24-31.]
  • Krokowicz L., Stojcev Z., Kaczmarek B.F., Kociemba W., Kaczmarek E., Walkowiak J., Krokowicz P., Drews M., Banasiewicz T. Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis--a prospective randomized study. Int J Colorectal Dis. 2014 Mar;29(3):387-93. doi: 10.1007/s00384-013-1807-5
  • Лазебник Л.Б., Левченко С.В. Симптоматическая дивертикулярная болезнь толстой кишки у больных старших возрастных групп: клиника и диагностика ее ишемического варианта. Практическая медицина. 2014;1 (77):94-98 [Lazebnik L.B., Levchenko S.V. Symptomatic diverticular colonal disease in seniour age groups: clinic and diagnostics of its ishemic type. Practical medicine. 2014;1 (77):94-98.]
  • Ford A.C., Talley N.J., Spiegel B.M. et al. Effect of fiber, antispasmodics and peppermint oil in the treatment od irritable bowel syndrome: systematic review and metaanalysis. BMJ, 2008, Now, 337 doi: https://doi.org/10.1136/bmj.a2313
  • Макарчук П.А. Сравнительная оценка эффективности спазмолитиков при синдроме раздраженного кишечника. Дисс. к.м.н., М, 20007, 40 стр. [Makarchuk P.A. Comparative estimation of spasmolytics efficacy in irritated bowel syndrome case. Diss of PhD, M.:2007, p. 40.]
  • Левченко С.В., Комиссаренко И.А., Голохвастова А.А., Мороз Е.В. и др. Эффективность масляной кислоты и инулина у больных с синдромом раздраженного кишечника: результаты многоцентрового исследования. Лечащий врач. 2018;2:53-60 [Levchenko S.V., Komissarenko I.A., Golokhvastova A.A., Moroz E.V. and others. Efficacy of buteric acid and inuline in patients with irritated bowel syndrome patients: results of multicenter research. Attending physician. 2018;2:53-60.]
  • Попова Е.В. Нарушение состава кишечной микрофлоры в механизмах формирования клинико-морфологических проявлений у больных дивертикулярной болезнью толстой кишки. Дисс. к.м.н., 2012,121 стр. [Popova E.V. Gut flora compound disorder in the mechanisms of clinical morphological manifestations formation in patients with diverticular colonal disease. Diss. of PhD., 2012, p. 121.]
  • Lanas A., Ponce J., Bignamini A., Mearin F. One year intermittent rifaximin plus fibers supplementation vs. fibers supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study. Dig Liver Dis. 2013 Feb;45(2):104-9. doi: 10.1016/j.dld.2012.09.006
  • Kechagias A., Rautio T., Kechagias G., Mäkelä J. The role of C-reactive protein in the prediction of the clinical severity of acute diverticulitis.. Am Surg. 2014 Apr;80(4):391-5
  • Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis (NCT00695643). 2009. Available from: URL:http://www.clinicaltrials.gov/ct2/show/NCT00695643
  • Gatta L, Vakil N, Vaira D, et al. Efficacy of 5-ASA in the treatment of colonic diverticular disease. J Clin Gastroenterol. 2010 Feb;44(2):113–9
  • Raskin J.B., Kamm M.A., Jamal M.M., Márquez J., Melzer E., Schoen R.E., Szalóki T., Barrett K., Streck P. Mesalamine Does Not Prevent Recurrent Diverticulitis in Phase 3 Controlled Trials. Gastroenterology. 2014 Jul 16. pii: S0016-5085(14)00900-7. doi: 10.1053/j.gastro.2014.07.004


    • About the Autors

    Svetlana V. Levchenko, PhD., associate professor of the Department of outpatient t herapy of A.I. Yevdokimov Moscow state university of medicine and dentistry. Address: 109074, Moscow, 7 Kitajgorodsky proezd Str. Tel.: +74955536804. E-mail: sv_levchenko@list.ru


    Similar Articles

    Back to Content

    Бионика Медиа